IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
Authors
Keywords
Osteosarcoma, IGF1R signaling, Signal transduction, IGF1R, OSI-906, Bone neoplasm, Sarcoma
Journal
BMC CANCER
Volume 13, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-05-20
DOI
10.1186/1471-2407-13-245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche
- (2015) Yusuke Shiozawa et al. NEOPLASIA
- The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma
- (2012) Alexander B. Mohseny et al. EUROPEAN JOURNAL OF CANCER
- Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data
- (2012) Marieke L. Kuijjer et al. GENES CHROMOSOMES & CANCER
- Phase II Study of Ganitumab, a Fully Human Anti–Type-1 Insulin-Like Growth Factor Receptor Antibody, in Patients With Metastatic Ewing Family Tumors or Desmoplastic Small Round Cell Tumors
- (2012) William D. Tap et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs
- (2012) Heidi M. Namløs et al. PLoS One
- Height at diagnosis and birth-weight as risk factors for osteosarcoma
- (2011) Lisa Mirabello et al. CANCER CAUSES & CONTROL
- Relationship between height at diagnosis and bone tumours in young people: a meta-analysis
- (2011) Ramandeep S. Arora et al. CANCER CAUSES & CONTROL
- Insulin-like Growth Factor-Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
- (2011) D. Chen et al. CLINICAL CANCER RESEARCH
- Insulin Growth Factor-2 Binding Protein 3 (IGF2BP3) Is a Glioblastoma-specific Marker That Activates Phosphatidylinositol 3-Kinase/Mitogen-activated Protein Kinase (PI3K/MAPK) Pathways by Modulating IGF-2
- (2011) Ramaswamy Suvasini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
- (2011) Alberto S. Pappo et al. JOURNAL OF CLINICAL ONCOLOGY
- Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma
- (2011) Heribert Juergens et al. JOURNAL OF CLINICAL ONCOLOGY
- Signalling by insulin and IGF receptors: supporting acts and new players
- (2011) Kenneth Siddle JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling
- (2011) C Garofalo et al. ONCOGENE
- Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival
- (2010) David F Schaeffer et al. BMC CANCER
- Biological Rationale and Current Clinical Experience With Anti-Insulin-Like Growth Factor 1 Receptor Monoclonal Antibodies in Treating Sarcoma
- (2010) David Olmos et al. CANCER JOURNAL
- Pharmacokinetically Guided Phase 1 Trial of the IGF-1 Receptor Antagonist RG1507 in Children with Recurrent or Refractory Solid Tumors
- (2010) R. Bagatell et al. CLINICAL CANCER RESEARCH
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
- Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
- (2010) E. Buck et al. MOLECULAR CANCER THERAPEUTICS
- Initial testing (stage 1) of AZD6244 (ARRY-142886) by the pediatric preclinical testing program
- (2010) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- Prognostic and predictive biomarkers of canine osteosarcoma
- (2010) Gayathri Thevi Selvarajah et al. VETERINARY JOURNAL
- Erratum: Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
- (2009) A-M Cleton-Jansen et al. BRITISH JOURNAL OF CANCER
- Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment
- (2009) Y. M. Schrage et al. CANCER RESEARCH
- Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-1 receptor and insulin receptor
- (2009) Mark J Mulvihill et al. Future Medicinal Chemistry
- Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort
- (2009) Laura Ottaviano et al. GENES CHROMOSOMES & CANCER
- Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma
- (2009) Yongping Cai et al. JOURNAL OF PATHOLOGY
- SCF, BDNF, and Gas6 Are Regulators of Growth Plate Chondrocyte Proliferation and Differentiation
- (2009) Michele R. Hutchison et al. MOLECULAR ENDOCRINOLOGY
- Development of IGF-IR inhibitors in pediatric sarcomas
- (2009) E. Anders Kolb et al. Current Oncology Reports
- The insulin-like growth factor system and sarcomas
- (2008) Bart Rikhof et al. JOURNAL OF PATHOLOGY
- Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program
- (2008) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- TP53 Gene Mutations in Canine Osteosarcoma
- (2008) JOLLE KIRPENSTEIJN et al. VETERINARY SURGERY
- Insulin-like growth factor-binding proteins and bone metabolism
- (2007) Cheryl A. Conover AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now